AGFA-GEVAERT NV(EBR:AGFB) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to AGFB. AGFB was compared to 11 industry peers in the Health Care Technology industry. While AGFB seems to be doing ok healthwise, there are quite some concerns on its profitability. AGFB is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

AGFB had negative earnings in the past year.

AGFB had a negative operating cash flow in the past year.

In the past 5 years AGFB reported 4 times negative net income.

AGFB had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

AGFB's Return On Assets of -2.61% is on the low side compared to the rest of the industry. AGFB is outperformed by 72.73% of its industry peers.

AGFB has a worse Return On Equity (-9.76%) than 72.73% of its industry peers.

Looking at the Return On Invested Capital, with a value of 0.29%, AGFB is doing worse than 72.73% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-2.61%
ROE	-9.76%
ROIC	0.29%

ROA(3y)-6.95%

ROA(5y)0.93%

ROE(3y)-23.67%

ROE(5y)-5.43%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AGFB has a worse Operating Margin (0.35%) than 72.73% of its industry peers.

In the last couple of years the Operating Margin of AGFB has declined.

AGFB has a Gross Margin of 31.53%. This is amonst the worse of the industry: AGFB underperforms 81.82% of its industry peers.

In the last couple of years the Gross Margin of AGFB has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	0.35%
PM (TTM)	N/A
GM	31.53%

OM growth 3Y-17.71%

OM growth 5Y-24.95%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.5%

GM growth 5Y-0.57%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AGFB is destroying value.

The number of shares outstanding for AGFB remains at a similar level compared to 1 year ago.

The number of shares outstanding for AGFB has been reduced compared to 5 years ago.

AGFB has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.15 indicates that AGFB is not a great score, but indicates only limited risk for bankruptcy at the moment.

AGFB has a Altman-Z score (2.15) which is in line with its industry peers.

A Debt/Equity ratio of 0.40 indicates that AGFB is not too dependend on debt financing.

The Debt to Equity ratio of AGFB (0.40) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.4
Debt/FCF	N/A
Altman-Z	2.15

ROIC/WACC0.03

WACC9.62%

2.3 Liquidity

A Current Ratio of 2.14 indicates that AGFB has no problem at all paying its short term obligations.

With a Current ratio value of 2.14, AGFB perfoms like the industry average, outperforming 54.55% of the companies in the same industry.

AGFB has a Quick Ratio of 1.24. This is a normal value and indicates that AGFB is financially healthy and should not expect problems in meeting its short term obligations.

AGFB has a Quick ratio (1.24) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	2.14
Quick Ratio	1.24

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AGFB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.23%, which is quite impressive.

Looking at the last year, AGFB shows a very negative growth in Revenue. The Revenue has decreased by -25.77% in the last year.

The Revenue for AGFB have been decreasing by -12.10% on average. This is quite bad

EPS 1Y (TTM)54.23%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)-25.77%

Revenue growth 3Y-12.37%

Revenue growth 5Y-12.1%

Sales Q2Q%-0.35%

3.2 Future

AGFB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.78% yearly.

AGFB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.72% yearly.

EPS Next Y81.42%

EPS Next 2Y40.26%

EPS Next 3Y29.78%

EPS Next 5YN/A

Revenue Next Year1.04%

Revenue Next 2Y2.35%

Revenue Next 3Y2.72%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AGFB. In the last year negative earnings were reported.

Also next year AGFB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

AGFB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AGFB is cheaper than 81.82% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	4.63

4.3 Compensation for Growth

A more expensive valuation may be justified as AGFB's earnings are expected to grow with 29.78% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y40.26%

EPS Next 3Y29.78%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for AGFB!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AGFA-GEVAERT NV

EBR:AGFB (1/22/2025, 7:00:00 PM)

0.765

+0.01 (+0.79%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)11-14 2024-11-14

Earnings (Next)N/A N/A

Inst Owners55.01%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap118.44M

Analysts74

Price Target1.2 (56.86%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)22.97%

Min EPS beat(2)-96.08%

Max EPS beat(2)142.02%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-8.02%

Min Revenue beat(2)-11.52%

Max Revenue beat(2)-4.53%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-11.32%

PT rev (3m)-22.95%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)17.07%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)-0.26%

Revenue NY rev (3m)-0.76%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.1
P/FCF	N/A
P/OCF	N/A
P/B	0.31
P/tB	0.86
EV/EBITDA	4.63

EPS(TTM)-0.65

EYN/A

EPS(NY)-0.02

Fwd EYN/A

FCF(TTM)-0.28

FCFYN/A

OCF(TTM)-0.01

OCFYN/A

SpS7.29

BVpS2.45

TBVpS0.88

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-2.61%
ROE	-9.76%
ROCE	0.39%
ROIC	0.29%
ROICexc	0.31%
ROICexgc	0.41%
OM	0.35%
PM (TTM)	N/A
GM	31.53%
FCFM	N/A

ROA(3y)-6.95%

ROA(5y)0.93%

ROE(3y)-23.67%

ROE(5y)-5.43%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3Y-23.56%

ROICexcg growth 5Y-30.85%

ROICexc growth 3Y-23.57%

ROICexc growth 5Y-27.42%

OM growth 3Y-17.71%

OM growth 5Y-24.95%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.5%

GM growth 5Y-0.57%

F-Score4

Asset Turnover0.8

Health

		Industry Rank	Sector Rank
Debt/Equity	0.4
Debt/FCF	N/A
Debt/EBITDA	3.26
Cap/Depr	95.35%
Cap/Sales	3.63%
Interest Coverage	0.25
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.14
Quick Ratio	1.24
Altman-Z	2.15

F-Score4

WACC9.62%

ROIC/WACC0.03

Cap/Depr(3y)56.62%

Cap/Depr(5y)51.62%

Cap/Sales(3y)2.44%

Cap/Sales(5y)2.23%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)54.23%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next Y81.42%

EPS Next 2Y40.26%

EPS Next 3Y29.78%

EPS Next 5YN/A

Revenue 1Y (TTM)-25.77%

Revenue growth 3Y-12.37%

Revenue growth 5Y-12.1%

Sales Q2Q%-0.35%

Revenue Next Year1.04%

Revenue Next 2Y2.35%

Revenue Next 3Y2.72%

Revenue Next 5YN/A

EBIT growth 1Y102.33%

EBIT growth 3Y-27.89%

EBIT growth 5Y-34.02%

EBIT Next Year241.58%

EBIT Next 3Y70.84%

EBIT Next 5YN/A

FCF growth 1Y61.61%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y97.7%

OCF growth 3YN/A

OCF growth 5YN/A

AGFA-GEVAERT NV (AGFB.BR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens